AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The model has uncovered a hidden layer of molecular code that shapes biological organization, adding new dimensions of ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

AI, and cloud computing towards improving existing computational methods while exploring new algorithms to address a wide range of drug design challenges. “We look forward to helping expedite ...

Explore the transformative power of responsible AI across industries, emphasizing security, MLOps, and compliance. As AI ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.